Table 1 |
|||||||
|
Summary of published computer-assisted glucose regulation protocols, designed for critically ill patients |
|||||||
|
Reference |
N |
Patient type |
APACHE II |
Target range (mmol/L) |
Performance |
Hypoglycaemiaa |
Measurements per patient per day |
|
|
|||||||
|
Boord et al. [21] |
204 |
Surgical ICU |
? |
4.4 to 6.1 |
49% of time in range |
0.2% <2.2 mmol/L |
~18 (12 to 24)b |
|
Cordingley et al. [22] |
16 |
Mixed ICU |
16.6 |
4.4 to 6.1 |
63% of time in range |
0 <2.2 mmol/L |
10.9 |
|
Davidson et al. [23] |
5,808 |
General medical and surgical floors |
? |
Variable |
'Stable glucose' |
0.6% <2.8 mmol/L |
~18 (12 to 24)b |
|
Dortch et al. [24] |
243 |
Trauma ICU |
ISS 27.5 |
4.4 to 6.1 |
42% of measurements in range |
0.2% <2.2 mmol/L |
10.7 |
|
Hermayer et al. [25] |
66 |
CABG |
? |
4.4 to 6.7 |
Mean BG 6.4 mmol/L |
0.10% <2.2 mmol/L |
16.2c |
|
Horovorka et al. [26] |
30 |
Cardiac surgery |
? |
4.4 to 6.1 |
60% of time in range |
0 <2.9 mmol/L |
16 |
|
Juneja et al. [27] |
2,398 |
Mixed ICU |
? |
4.4 to 6.1 |
61% of measurements in range |
0.4% <2.8 mmol/L |
~18 (12 to 24)b |
|
Laha et al. [28] |
661 |
Mixed ICU |
16 |
4.5 to 7.2 |
95% of measurements in the range 3.7 to 12.1 mmol/L |
1.7% of patients with a single episode <2.2 mmol/L |
~12 (6 to 24)d |
|
Meyenaar et al. [29] |
179 |
Mixed ICU |
13 |
4.5 to 7.5 |
53% of time in range |
0.05% <2.2 mmol/L |
3.4 |
|
Morris et al. [30] |
775 |
Mixed ICU |
21.8 |
4.4 to 6.1 |
42% of measurements in range |
0.33% <2.2 mmol/L |
~12 (6 to 24)d |
|
NICE-SUGAR [13]: |
3,054 |
Mixed ICU |
21.1 |
4.5 to 6.0 |
Mean time-weighted BG |
6.8% <2.2 mmol/L |
~12 (6 to 24)d |
|
intensive control |
6.4 mmol/L |
||||||
|
NICE-SUGAR [13]: conventional control |
3,050 |
Mixed ICU |
21.1 |
8.0 to 10.0 |
Mean time-weighted BG 8.0 mmol/L |
0.5% <2.2 mmol/L |
~12 (6 to 24)d |
|
Pachler et al. [31] |
25 |
Medical ICU |
26.6 |
4.4 to 6.1 |
HGI = 0.4 mmol/L |
1 episode <2.2 mmol/L |
12.3 |
|
Plank et al. [32] |
30 |
Cardiac surgery |
11.4 |
4.4 to 6.1 |
52% of time in range |
0 <2.2 mmol/L |
24 |
|
Rood et al. [33] |
66 |
Mixed ICU |
19.5 |
4.0 to 7.0 |
54% of time in range |
0.09% of time <2.5 mmol/L |
9.9c |
|
Saager et al. [34] |
20 |
Cardiac surgery |
? |
5.0 to 8.3 |
84% of time in range |
5 episodes <3.3 mmol/L |
24 |
|
Shulman et al. [35] |
50 |
Mixed ICU |
23 |
4.4 to 6.1 |
23% of time in range |
0.04% of time <2.2 mmol/L |
12.7 |
|
Thomas et al. [36] |
603 |
Mixed ICU |
14.4 |
5.4 to 7.1 |
85% of measurements <8 mmol/L |
19 episodes |
~12 (6 to 24)d |
|
Toschlog et al. [37] |
128 |
Trauma |
ISS 24.5 |
4.4 to 7.2 |
Mean BG 6.4 mmol/L |
32% of patients with a single episode <2.8 mmol/L |
? |
|
Vogelzang et al. [38] |
2,800 |
Mixed ICU |
14 |
4.0 to 7.5 |
67% of time in range |
0.04% <2.2 mmol/L |
5.9 |
|
|
|||||||
|
aHypoglycaemia is represented as the proportion of all measurements, unless otherwise specified. bNo exact data, but protocol has 'hourly to two-hourly measurements'. c Calculated from number of measurements and length of stay. dNo exact data, but protocol has 'hourly to four-hourly measurements'. APACHE, Acute Physiology and Chronic Health Evaluation II; BG, blood glucose; CABG, coronary artery bypass grafting; HGI, hyperglycaemic index; ISS, Injury Severity Score; NICE-SUGAR, The Normoglycaemia in Intensive Care Evaluation - Survival Using Algorithm Regulation. |
|||||||
|
Hoekstra et al. Critical Care 2009 13:223 doi:10.1186/cc8023 |
|||||||